AMYLIN PHARMACEUTICALS INC: current_assets

Value{"amount": 668493000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"}
Period (as of 2011-03-31)
Statuscurrent
EntityAMYLIN PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-11-127421 · Open the official SEC filing →
Retrieved: 2026-08-19T08:48:00.440667+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000881464/current-assets/2011-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ca4a17f4-4824-4481-bece-bfbb8f9d4a65

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies